Clinical trials: Peripheral Nerve Stimulation in MRI

Neurofibromatosis 1

Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1

• Completed
• Age: 8 to 16 years
• Phase 2
• Results posted

Children with neurofibromatosis type 1 (NF1) commonly suffer from the effects of cognitive, behavioral, and motor impairments. At present, there is no specific treatment for this NF1 complication.

Trial name

DoDNAC (NCT04481048)

Testing

N-Acetyl cysteine

Where

United States

Volunteers

25 people, healthy volunteers welcome

Sponsor

Children's Hospital Medical Center, Cincinnati